Symbol="ARWR"
AssetType="Common Stock"
Name="Arrowhead Pharmaceuticals Inc"
Description="Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California."
CIK="879407"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TRADE & SERVICES"
Industry="SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH"
Address="225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US"
FiscalYearEnd="September"
LatestQuarter="2023-03-31"
MarketCapitalization="3856951000"
EBITDA="-140096000"
PERatio="None"
PEGRatio="-1.32"
BookValue="4.181"
DividendPerShare="0"
DividendYield="0"
EPS="-1.38"
RevenuePerShareTTM="2.571"
ProfitMargin="-0.551"
OperatingMarginTTM="-0.552"
ReturnOnAssetsTTM="-0.118"
ReturnOnEquityTTM="-0.332"
RevenueTTM="272800000"
GrossProfitTTM="243231000"
DilutedEPSTTM="-1.38"
QuarterlyEarningsGrowthYOY="0.098"
QuarterlyRevenueGrowthYOY="-0.036"
AnalystTargetPrice="62.15"
TrailingPE="-"
ForwardPE="111.11"
PriceToSalesRatioTTM="14.71"
PriceToBookRatio="8.04"
EVToRevenue="11.97"
EVToEBITDA="-17.32"
Beta="0.968"
num_52WeekHigh="48.48"
num_52WeekLow="23.09"
num_50DayMovingAverage="35.55"
num_200DayMovingAverage="33.13"
SharesOutstanding="106900000"
DividendDate="None"
ExDividendDate="None"
symbol="ARWR"
open="35.69"
high="36.00"
low="35.05"
price="35.10"
volume="840691.00"
latest_trading_day="2023-07-26"
previous_close="35.62"
change="-0.52"
change_percent="-1.4599%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="1062250"
Change_recent_avg="-0.1"
Delta_recent_avg="1.35"
Variance_recent_avg="0.68"
Change_ratio_recent_avg="-0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="129"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0047.jpeg"
image_negative_thumbnail_id_2="1112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_neutral_thumbnail_id_1="561"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0038.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="609"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
